title: Re: Geng et al.: XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis (Urology 2009;74:648-653).
authors.forename: Bingbing
authors.initials: B
authors.lastname: Wei
authors.forename: Zhuoqun
authors.initials: Z
authors.lastname: Xu
authors.forename: Jun
authors.initials: J
authors.lastname: Ruan
authors.forename: Ming
authors.initials: M
authors.lastname: Zhu
authors.forename: Qiang
authors.initials: Q
authors.lastname: Hu
authors.forename: Qiang
authors.initials: Q
authors.lastname: Wang
authors.forename: Zhirong
authors.initials: Z
authors.lastname: Wang
authors.forename: Zhiqiang
authors.initials: Z
authors.lastname: Yan
mesh_terms: D004268:DNA-Binding Proteins / Q000235:genetics*; D006801:Humans; D008297:Male; D011110:Polymorphism, Genetic; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins